Six new indications/molecules were approved by FDA in February 2021 including the following: Melphalan flufenamide in combination with dexamethasone for adult...
News
What is Alzheimer's disease? Alzheimer's is an irreversible neurodegenerative disease that usually starts slowly and gradually worsens over time. The exact cause of...
In January 2021, the FDA approved the following new indications/Molecules. Combination of nivolumab and cabozantinib as first-line treatment for patients...
In December 2020, five (5) molecules were approved for the treatment of hematology/oncology disorders. Osimertinib for adjuvant therapy after tumor...
Sickle cell disease is a hereditary problem that causes a type of faulty hemoglobin in red blood cells. Hemoglobin carries...
It seems that the hope of gene therapy for transfusion-dependent β-thalassemia (TDT) is becoming so close. During the 62nd American Society...
In November, three (3) indications/molecules were approved by FDA: Sonalleve MR-HIFU system for the treatment of osteoid osteoma in the...
Beta thalassemias is an inherited blood disorder that results from the reduced or absent synthesis of the beta chains of hemoglobin....
What is B-cell lymphoma? B-cell lymphomas are a type of blood cancer that developed more frequently in immunocompromised patients and...
The answers to the above question are not, but there is a condition called Barrett’s esophagus where cells that make...
